GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA9, CDK6, CNR1, CNR2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, HSD17B2, IGF1R, MMP2, MMP9, PIK3CA, PPARA, PRKCB, PRKCD, PRKCE, PTGES, PTGS2, RORC, SRC, TRPV1, TYR |
11.1969 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, HSD17B2, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP2, MMP9, PIK3CA, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, RORC, SRC, TRPV1, TYR |
11.1825 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CHRM1, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, HSD17B2, HTR2A, HTR2B, HTR2C, KDR, MAOA, MET, MTNR1B, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTGS1, PTGS2, SLC22A1, SLC22A2, SLC22A3, SRC, TRPV1, XDH |
11.0127 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP2, PIK3CA, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, RORC, SRC, TRPV1, TYR |
10.8515 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CA9, CDK6, CNR1, CNR2, CYP1A1, CYP1B1, FABP3, HTR2A, HTR2B, HTR2C, KDR, PRKCD, PRKCE, PRKCG, PTGS2, SRC, TRPV1 |
9.25123 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CYP1A1, CYP1A2, ESR1, FABP3, FLT3, HSD17B2, PRKCE, PTGES, PTGS2, RORC, SRC, TYR |
8.45254 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CYP1B1, ESR1, FLT3, GLO1, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC, TOP2A, TRPV1, XDH |
8.31993 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CYP1B1, ESR1, FLT3, GLO1, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC, TOP2A, TRPV1, XDH |
8.29204 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CYP1B1, ESR1, FLT3, GLO1, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC, TOP2A, TRPV1, XDH |
7.62964 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, BCL2, CA2, CA9, CNR1, CYP1A1, CYP1A2, CYP1B1, ESR1, FLT3, PRKCE, PRKCG, PTGES, PTGS2, RORC, SRC, TRPV1, TYR |
7.62964 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, PPARA, PRKCD, PRKCE, PTGS2, SRC |
7.34108 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GLO1, HTR2B, HTR2C, PIK3CA, PIM1, PPARA, PTGES, PTGS1, PTGS2, TBXAS1, TYR, XDH |
7.23055 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CNR1, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP1, MMP2, MMP9, MTNR1A, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
6.85432 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, PRKCD, PTGES, PTGS2, SRC |
6.79038 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, CDK6, CNR1, HTR2A, HTR2B, HTR2C, KDR, PIK3CB, PRKCE, PTGS2, SRC, TRPV1 |
6.6674 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, PRKCD, SRC |
6.6674 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.61118 |
[BP] GO:0030168 |
platelet activation
|
AXL, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
6.5884 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FUT7, HSD17B2, MET, PIK3CA, PIK3CB, PPARA, PTGES, PTGS1, PTGS2, TBXAS1, TRPV1 |
6.5884 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCE, PTGS2, PTPN1, SRC, XDH |
6.5884 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CDK6, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SRC, TRPV1 |
6.56562 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SRC, TRPV1 |
6.48818 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, APEX1, AXL, BCL2, CA12, CA2, CA7, CNR1, ESR1, FABP3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, MET, MTNR1B, PIK3CA, PIK3CB, PRKCB, PRKCE, SRC, TRPV1 |
6.47007 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
6.36788 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
6.34203 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.29847 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CNR1, CYP1A1, FABP3, FLT3, HTR2A, HTR2B, HTR2C, PPARA, PRKCD, PRKCE, PTGS2, RORC, SRC |
6.27865 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGES, PTGS1, PTGS2, TBXAS1 |
6.15253 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CDK6, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, HSD17B2, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS1, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, TYR |
6.12689 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, CNR1, ESR1, FABP3, FABP4, HTR2A, HTR2B, HTR2C, MET, MTNR1B, PIK3CA, PIK3CB, PRKCB, PRKCE, TRPV1 |
6.12689 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, GLO1, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC |
6.09181 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CDK6, CYP1B1, ESR1, IGF1R, MMP2, MMP9, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SRC, TRPV1 |
5.97183 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CNR1, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP1, MMP2, MMP9, MTNR1A, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
5.95656 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CYP1A2, ESR1, FABP3, FLT3, PPARA, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
5.93934 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, GLO1, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC |
5.92201 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGES, PTGS1, PTGS2, TBXAS1 |
5.87057 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, KDR, PRKCD, PRKCE, SRC |
5.87057 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.7541 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, FLT3, HTR2B, HTR2C, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, XDH |
5.70244 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC22A1, SLC22A2, SLC22A3, TRPV1 |
5.69209 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, AURKB, AXL, BCL2, CYP1B1, ESR1, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
5.68663 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGES, PTGS1, PTGS2, TBXAS1 |
5.67704 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2, HTR2A, HTR2C, MTNR1B, PRKCA, PRKCE, SLC22A1 |
5.66113 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, HTR2A, HTR2B, HTR2C, KDR, PRKCE, SRC, TRPV1 |
5.66113 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, APEX1, AXL, BCL2, CA2, CA7, CDK6, CHRM1, CNR1, CYP19A1, CYP1B1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, MTNR1B, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TRPV1 |
5.60039 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CDK6, CYP1B1, KDR, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
5.51566 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, FLT3, HTR2B, IGF1R, KDR, MET, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
5.51566 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CHRM1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B2, HTR2B, HTR2C, IGF1R, KDR, MAOA, MET, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS1, PTGS2, PTPN1, RORC, SLC22A2, SRC, TBXAS1, TOP2A, TYR, XDH |
5.50043 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, PRKCD, SRC |
5.4642 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CDK6, CHRM1, CHRM2, CNR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, FUT7, GLO1, HSD17B2, HTR2A, HTR2B, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCD, PTGS2, RORC, SRC, TOP2A, TYR |
5.42101 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, FLT3, HTR2B, HTR2C, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, XDH |
5.38076 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, GLO1, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC |
5.32513 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
BCL2, CDC25B, FABP3, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, MTNR1A, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
5.2597 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
BCL2, CDC25B, FABP3, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, MTNR1A, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
5.2597 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CYP1A2, ESR1, FABP3, FLT3, IGF1R, MMP2, PPARA, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
5.25374 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, CNR1, CNR2, FABP3, FLT3, IGF1R, MMP2, PPARA, PRKCD, PRKCE, PRKCG, PTGS2, SRC, TRPV1, TYR |
5.2419 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
5.18136 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
5.16364 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CHRM1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B2, HTR2B, HTR2C, IGF1R, KDR, MAOA, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS1, PTGS2, PTPN1, RORC, SLC22A2, SRC, TBXAS1, TOP2A, TRPV1, TYR, XDH |
5.12451 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1 |
5.08961 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, FLT3, HTR2B, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
5.01226 |
[BP] GO:0007200 |
None
|
CHRM1, CHRM2, CHRM4, ESR1, HTR2A, HTR2B, HTR2C |
4.99975 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, AXL, BCL2, CA2, CA7, CHRM1, CNR1, CYP19A1, HTR2A, HTR2B, HTR2C, MMP9, MTNR1B, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TRPV1 |
4.98739 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, AXL, BCL2, CNR1, CYP1B1, FABP4, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, XDH |
4.96424 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, CNR1, CNR2, FABP3, FLT3, IGF1R, MMP2, PPARA, PRKCD, PRKCE, PRKCG, PTGS2, SRC, TRPV1, TYR |
4.85478 |
[BP] GO:0019371 |
None
|
PTGES, PTGS1, PTGS2, TBXAS1 |
4.82323 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
BCL2, CDC25B, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.8024 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX5, ALPL, AXL, BCL2, CHRM1, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, ESR1, FABP4, HSD17B2, HTR2A, HTR2B, HTR2C, IGF1R, MET, MMP1, MMP2, MMP9, PIK3CA, PIM1, PPARA, PRKCD, PRKCG, PTGS2, RORC, SRC, TRPV1, TYR |
4.79613 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, MET, PIK3CA, PIK3CB, PPARA, PTGES, PTGS1, PTGS2, TBXAS1 |
4.70387 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CHRM1, CYP1B1, ESR1, FABP3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP2, MMP9, PIM1, PRKCA, PTGES, PTGS1, PTGS2, SRC, XDH |
4.70087 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGES, PTGS1, PTGS2, TBXAS1 |
4.64728 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
4.62526 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, ESR1, MTNR1A, MTNR1B, PPARA, PRKCG, RORC, SRC, TOP2A |
4.61 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC22A1, SLC22A2, SLC22A3, TRPV1 |
4.60445 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
BCL2, CDC25B, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.58301 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGES, PTGS1, PTGS2, TBXAS1 |
4.58301 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, CNR1, CNR2, PRKCE |
4.58301 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CHRM1, CHRM4, CYP1A1, ESR1, FLT3, MET, PIK3CB, PIM1, PRKCD, SRC, TYR |
4.55378 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1B1, ESR1, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP9, MTNR1B, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.52267 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, HTR2C, PRKCD, PTGS2 |
4.5183 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CHRM1, ESR1, FLT3, HTR2A, HTR2B, IGF1R, KDR, MMP2, MMP9, PIM1, PRKCA, PTGS2 |
4.50858 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGES, PTGS1, PTGS2, TBXAS1 |
4.49225 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, PRKCD, SRC |
4.48379 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, PRKCD, SRC |
4.48379 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B2, MAOA, NQO2, PTGS1, PTGS2, TBXAS1, TYR, XDH |
4.45943 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1B1, ESR1, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP9, MTNR1B, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.43358 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.42633 |
[BP] GO:0007165 |
signal transduction
|
AKR1B1, AXL, BCL2, CA1, CA2, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CYP1B1, ESR1, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP2, MMP9, MTNR1A, MTNR1B, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTPN1, RORC, SRC, TRPV1 |
4.42633 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CYP19A1, CYP1B1, ESR1, FABP3, FABP4, GLO1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
4.42633 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.42612 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, HTR2A, HTR2B, HTR2C, PPARA, PRKCB, PRKCE, SLC22A1, SLC22A2, SLC22A3, SLC47A1, TRPV1 |
4.35489 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
BCL2, CDC25B, FABP3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, MTNR1A, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.34986 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
BCL2, CDC25B, FABP3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, MTNR1A, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.29657 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, PRKCD, SRC |
4.27991 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
4.24377 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC |
4.23384 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, PRKCD, PRKCE |
4.2283 |
[BP] GO:0007187 |
None
|
CHRM1, CHRM2, CHRM4, CNR1, CNR2, HTR6, MTNR1A, MTNR1B |
4.12656 |
[BP] GO:0001775 |
cell activation
|
ALOX5, AXL, BCL2, FLT3, FUT7, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, TRPV1 |
4.11854 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
4.11854 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.11854 |
[BP] GO:0042325 |
regulation of phosphorylation
|
BCL2, CDC25B, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.10207 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM4 |
4.08372 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B, HTR2C |
4.08372 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
BCL2, CDC25B, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.02705 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, PRKCD, PTGS1, PTGS2, SRC |
4.00251 |
[BP] GO:0051209 |
None
|
HTR2A, HTR2B, HTR2C, PRKCE, TRPV1 |
3.9457 |
[BP] GO:0051283 |
None
|
HTR2A, HTR2B, HTR2C, PRKCE, TRPV1 |
3.9457 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, CYP1A1, CYP1B1, ESR1, FLT3, PTGS2, RORC, SRC, TRPV1 |
3.92079 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGES, PTGS2, SRC |
3.83194 |
[BP] GO:0040012 |
regulation of locomotion
|
APEX1, BCL2, CDK6, CHRM1, CHRM4, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
3.83194 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM4 |
3.82059 |
[BP] GO:0031329 |
regulation of cellular catabolic process
|
APEX1, BCL2, CNR1, HTR2A, HTR2B, KDR, MET, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCG, PTPN1 |
3.7639 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, ESR1, FABP3, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, TRPV1 |
3.7639 |
[BP] GO:0032845 |
None
|
BCL2, HTR2A, HTR2B, HTR2C, PRKCE, SRC, TRPV1 |
3.7639 |
[BP] GO:0044092 |
negative regulation of molecular function
|
AURKB, CNR1, CNR2, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC |
3.7518 |
[BP] GO:0009894 |
regulation of catabolic process
|
APEX1, BCL2, CNR1, HTR2A, HTR2B, KDR, MET, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1 |
3.70852 |
[BP] GO:0006950 |
response to stress
|
ACHE, AKR1B1, APEX1, AXL, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, HTR2C, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS1, PTGS2, PTPN1, SRC, TOP2A, TRPV1 |
3.69961 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGES, PTGS2, SRC |
3.62817 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PPARA, PTGES, PTGS1, PTGS2, TBXAS1 |
3.62266 |
[BP] GO:0010511 |
None
|
HTR2A, HTR2B, HTR2C |
3.60987 |
[BP] GO:0099536 |
None
|
CHRM1, CHRM2, CHRM4, CNR1, HTR2A, HTR2C, HTR6, MTNR1B, PRKCG |
3.60715 |
[BP] GO:0099537 |
None
|
CHRM1, CHRM2, CHRM4, CNR1, HTR2A, HTR2C, HTR6, MTNR1B, PRKCG |
3.60715 |
[BP] GO:0007210 |
None
|
HTR2A, HTR2B, HTR2C, HTR6 |
3.60715 |
[BP] GO:0098664 |
None
|
HTR2A, HTR2B, HTR2C, HTR6 |
3.60715 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
BCL2, CDC25B, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
3.58294 |
[BP] GO:0097553 |
None
|
HTR2A, HTR2B, HTR2C, PRKCE, TRPV1 |
3.50935 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
AURKB, BCL2, CDC25B, ESR1, FABP3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, MTNR1A, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
3.49309 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, BCL2, CNR1, CYP1A1, HTR2A, PRKCD, PTGS2 |
3.49061 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, PIK3CB, PRKCA, PRKCD, PRKCE, PTPN1, SRC, XDH |
3.48565 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CYP19A1, CYP1B1, ESR1, FABP3, FABP4, GLO1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
3.45882 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
FLT3, HTR2A, HTR2B, HTR2C, KDR, PIK3CB, PRKCA, PRKCE, PTPN1, SRC, XDH |
3.40378 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2 |
3.39255 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PRKCE, PTGES, PTGS2, SRC |
3.39255 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, PRKCD |
3.39255 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
3.39255 |
[BP] GO:0016572 |
histone phosphorylation
|
AURKB, PRKCA, PRKCB, PRKCD |
3.3696 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CYP19A1, CYP1B1, ESR1, FABP4, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, XDH |
3.34459 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
AURKB, BCL2, CDC25B, ESR1, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, MTNR1A, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
3.31677 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, HSD17B2 |
3.3141 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, AURKB, BCL2, CA2, CYP1A1, HTR2A, HTR2B, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SRC, TRPV1, TYR |
3.3141 |
[BP] GO:0060402 |
None
|
HTR2A, HTR2B, HTR2C, PRKCE, TRPV1 |
3.3141 |
[BP] GO:0006855 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2 |
3.3141 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
3.3141 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, FLT3, IGF1R, KDR, MET, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A |
3.2958 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, NQO2, PTGS1, RORC |
3.29242 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
BCL2, CA12, CA2, CA7, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, TRPV1 |
3.27353 |
[BP] GO:0007610 |
None
|
BCL2, CNR1, HTR2A, HTR2B, HTR2C, MTNR1A, PPARA, PRKCE, PRKCG, PTGS2, TRPV1 |
3.22117 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
BCL2, CA2, CA7, ESR1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB, PRKCB, PRKCE, TRPV1 |
3.20517 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SRC |
3.1893 |
[BP] GO:0031399 |
regulation of protein modification process
|
BCL2, CDC25B, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, XDH |
3.18654 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.18225 |
[BP] GO:0080134 |
regulation of response to stress
|
CDK6, CNR1, CNR2, CYP19A1, ESR1, FABP4, IGF1R, MET, MMP2, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, XDH |
3.17915 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2 |
3.17177 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, FABP3, IGF1R, PPARA, PRKCD, PTGS2, SRC, TRPV1 |
3.16113 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
3.16065 |
[BP] GO:0019725 |
cellular homeostasis
|
APEX1, BCL2, CA2, CA7, ESR1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB, PRKCB, PRKCE, TRPV1 |
3.13276 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
3.12138 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SRC |
3.11379 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
3.09935 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CYP1A1, CYP1A2, ESR1, FLT3, FUT7, GLO1, HTR2B, HTR2C, IGF1R, KDR, MAOA, MET, MMP1, MMP2, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TOP2A, TYR, XDH |
3.09573 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC |
3.09573 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, PRKCD, SRC |
3.06354 |
[BP] GO:0030003 |
cellular cation homeostasis
|
BCL2, CA2, CA7, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, TRPV1 |
3.06299 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, FLT3, IGF1R, KDR, PIM1, PRKCG, SRC |
3.03846 |
[BP] GO:0043207 |
response to external biotic stimulus
|
ALPL, AXL, BCL2, CDK6, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, PRKCD, PTGES, PTGS2, SRC |
3.03046 |
[BP] GO:0090087 |
None
|
ACHE, CA2, CHRM1, CNR1, HTR2B, HTR2C, MTNR1B, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC |
3.00983 |
[BP] GO:0060401 |
None
|
HTR2A, HTR2B, HTR2C, PRKCE, TRPV1 |
3.00775 |
[BP] GO:0006873 |
cellular ion homeostasis
|
BCL2, CA2, CA7, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, TRPV1 |
2.97733 |
[BP] GO:0015872 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.97396 |
[BP] GO:0015697 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.97396 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, HTR2A, HTR2B, IGF1R, KDR, MET, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC |
2.97144 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX5, PTGES, PTGS1, PTGS2 |
2.97142 |
[BP] GO:2000145 |
regulation of cell motility
|
APEX1, BCL2, CDK6, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
2.9649 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
BCL2, CDC25B, ESR1, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
2.96157 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, PRKCD, SRC |
2.94035 |
[BP] GO:0015695 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC47A1 |
2.9337 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
AURKB, BCL2, CDC25B, ESR1, FABP3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, MTNR1A, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
2.92604 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
BCL2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, TRPV1 |
2.91913 |
[BP] GO:0016477 |
cell migration
|
AXL, CNR2, CYP1B1, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, PIK3CA, PIK3CB, PRKCD, SRC |
2.91119 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SRC |
2.90059 |
[BP] GO:0007208 |
None
|
HTR2A, HTR2C |
2.90059 |
[BP] GO:0035408 |
None
|
PRKCA, PRKCB |
2.90059 |
[BP] GO:0007268 |
None
|
CHRM1, CHRM2, CHRM4, HTR2A, HTR2C, HTR6, MTNR1B, PRKCG |
2.90015 |
[BP] GO:0098916 |
None
|
CHRM1, CHRM2, CHRM4, HTR2A, HTR2C, HTR6, MTNR1B, PRKCG |
2.90015 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
CA2, CA7, PRKCE |
2.89946 |
[BP] GO:0001516 |
None
|
PTGES, PTGS1, PTGS2 |
2.89946 |
[BP] GO:0046457 |
None
|
PTGES, PTGS1, PTGS2 |
2.89946 |
[BP] GO:0009607 |
response to biotic stimulus
|
ALPL, AXL, BCL2, CDK6, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, PRKCD, PTGES, PTGS2, SRC |
2.88876 |
[BP] GO:0043271 |
negative regulation of ion transport
|
BCL2, CNR1, HTR2A, MMP9, PRKCE, PTGS2 |
2.87333 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CNR1, CYP1B1, MMP9, PIK3CB, PRKCD, PTGS2, SRC, TOP2A, TRPV1, XDH |
2.84448 |
[BP] GO:0055074 |
calcium ion homeostasis
|
BCL2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, TRPV1 |
2.84377 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
2.84377 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, CA2, CA7, CNR1, CNR2, HTR2A, PRKCE, PTGS2 |
2.82415 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, CA2, CA7, CNR1, CNR2, HTR2A, PRKCE, PTGS2 |
2.82415 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PIM1, PPARA, PTGES, PTGS1, PTGS2, TBXAS1, TYR |
2.81639 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CNR1, CYP1B1, MMP9, PIK3CB, PRKCD, PTGS2, SRC, TOP2A, TRPV1, XDH |
2.81515 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.81468 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
BCL2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, TRPV1 |
2.81079 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
CA2, CHRM1, CHRM2, CHRM4, CNR1, CNR2, ESR1, HTR2A, HTR2B, HTR2C, HTR6, MTNR1A, MTNR1B, PIK3CA, PIK3CB, SRC |
2.77361 |
[BP] GO:0015893 |
None
|
CA2, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2 |
2.77361 |
[BP] GO:0007154 |
None
|
AXL, BCL2, CHRM1, CHRM2, CHRM4, CNR1, HTR2A, HTR2C, HTR6, MTNR1B, PRKCG, PTGS2, TRPV1 |
2.77361 |
[BP] GO:0055080 |
cation homeostasis
|
BCL2, CA2, CA7, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, TRPV1 |
2.72886 |
[BP] GO:0051937 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.72886 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, ESR1, IGF1R, MET, MMP9, PRKCD, PTGS2, PTPN1, SRC, XDH |
2.71407 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
BCL2, CDC25B, ESR1, FLT3, HTR2A, HTR2B, HTR2C, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
2.69611 |
[BP] GO:0040011 |
locomotion
|
AXL, CNR2, CYP1B1, FUT7, HTR2B, HTR6, KDR, MET, MMP1, MMP9, PIK3CA, PIK3CB, PRKCD, SRC |
2.68183 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, FABP4, MMP9, PTGES, PTGS2 |
2.66654 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
BCL2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, TRPV1 |
2.66126 |
[BP] GO:0051270 |
regulation of cellular component movement
|
APEX1, BCL2, CDK6, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
2.65953 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.65589 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM4 |
2.65589 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.65589 |
[BP] GO:0065007 |
biological regulation
|
ACHE, AKR1B1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, GLO1, HSD17B2, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MAOA, MET, MMP1, MMP2, MMP9, MTNR1A, MTNR1B, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS1, PTGS2, PTPN1, RORC, SLC22A1, SLC22A2, SLC22A3, SRC, TOP2A, TRPV1, XDH |
2.63437 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MMP9, PTGS2, PTPN1, SRC |
2.63437 |
[BP] GO:0030334 |
regulation of cell migration
|
APEX1, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
2.62541 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CYP19A1, CYP1A1, CYP1A2, ESR1, FLT3, HSD17B2, KDR, PIK3CA, PPARA, SRC, TYR |
2.61197 |
[BP] GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress
|
BCL2, CYP1B1, PRKCD |
2.58516 |
[BP] GO:0046626 |
regulation of insulin receptor signaling pathway
|
PRKCB, PRKCD, PTPN1, SRC |
2.57325 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CNR1, CNR2, CYP19A1, ESR1, FABP4, KDR, MET, PPARA, PRKCA, PRKCD, PRKCG, PTGS2 |
2.57325 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CNR1, CYP1A1, PTGS2, SRC, TRPV1, TYR |
2.57285 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
AXL, BCL2, CA2, CDK6, CHRM1, CHRM2, CNR1, CYP1B1, ESR1, HTR2A, HTR2B, HTR2C, KDR, MET, MMP9, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, SRC, TRPV1, XDH |
2.5658 |
[BP] GO:0048870 |
cell motility
|
AXL, CNR2, CYP1B1, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, PIK3CA, PIK3CB, PRKCD, SRC |
2.56499 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CNR1, CYP1B1, MMP9, PIK3CB, PRKCD, PTGS2, SRC, TOP2A, TRPV1, XDH |
2.56419 |
[BP] GO:0031347 |
regulation of defense response
|
CNR1, CNR2, CYP19A1, ESR1, FABP4, MMP2, PPARA, PRKCD, PRKCE, PTGS2, PTPN1, SRC |
2.55929 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AXL, BCL2, CDC25B, CNR1, CYP19A1, CYP1A1, ESR1, HSD17B2, MMP2, MMP9, MTNR1A, PTGS2, SRC, TOP2A |
2.54612 |
[BP] GO:0046890 |
None
|
FABP3, HTR2A, HTR2B, HTR2C, PRKCD, PTGS2 |
2.5256 |
[BP] GO:0030155 |
regulation of cell adhesion
|
BCL2, CDK6, CYP1B1, KDR, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, SRC |
2.5256 |
[BP] GO:0072488 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.5256 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, HSD17B2, PIK3CA, PIK3CB, PTGES, PTGS1, PTGS2 |
2.5256 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
2.5256 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.5256 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
FLT3, HTR2A, HTR2B, IGF1R, PIK3CB, PRKCD, PTPN1, SRC |
2.5256 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, PRKCD, PTGS2, TRPV1, XDH |
2.5183 |
[BP] GO:0002682 |
regulation of immune system process
|
AXL, BCL2, CA2, CDK6, CNR1, CNR2, CYP19A1, ESR1, MMP2, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC |
2.51352 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, CDK6, KDR, PIK3CB, SRC |
2.51114 |
[BP] GO:0050994 |
None
|
CNR1, PPARA, PRKCD, PRKCE |
2.51114 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
AXL, BCL2, CA2, CNR1, CYP1B1, HTR2A, HTR2B, KDR, MET, MMP9, PIM1, PRKCA, PRKCB, PRKCE, PTGS2, SRC, TRPV1 |
2.49767 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B2, HTR2B, HTR2C, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS1, PTGS2, PTPN1, RORC, SRC, TBXAS1, TOP2A, TRPV1, TYR, XDH |
2.48934 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.48007 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, ESR1, FLT3, IGF1R, MMP2, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
2.4741 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, MAOA, PTGS2, SLC22A2, SLC22A3, TRPV1 |
2.46613 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PIM1, PPARA, PTGES, PTGS1, PTGS2, TBXAS1, TYR |
2.46028 |
[BP] GO:0001525 |
angiogenesis
|
CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PRKCA, PTGS2 |
2.45947 |
[BP] GO:2000147 |
positive regulation of cell motility
|
BCL2, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
2.42757 |
[BP] GO:0009605 |
response to external stimulus
|
ALPL, AXL, BCL2, CDK6, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, HTR2A, PRKCD, PTGES, PTGS2, SRC, TRPV1, TYR |
2.42476 |
[BP] GO:0070201 |
None
|
ACHE, BCL2, CHRM1, CNR1, HTR2B, MTNR1B, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC |
2.41476 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, MMP9, RORC |
2.41318 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
BCL2, CNR1, HTR2B, MET, PIK3CA, PPARA, PRKCG |
2.39495 |
[BP] GO:0046883 |
regulation of hormone secretion
|
CNR1, CYP19A1, HTR2A, HTR2C, MTNR1B, PRKCA, PRKCE |
2.39495 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PIM1, PPARA, PTGES, PTGS1, PTGS2, TBXAS1, TYR |
2.3946 |
[BP] GO:0065009 |
regulation of molecular function
|
AURKB, BCL2, CDC25B, CNR1, CNR2, CYP1B1, ESR1, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TRPV1, XDH |
2.36896 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.36896 |
[BP] GO:0015844 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.36896 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.36896 |
[BP] GO:0051282 |
None
|
HTR2A, HTR2B, HTR2C, PRKCE, TRPV1 |
2.35132 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
BCL2, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
2.35132 |
[BP] GO:0050996 |
None
|
PPARA, PRKCD, PRKCE |
2.31292 |
[BP] GO:0034097 |
response to cytokine
|
AXL, BCL2, FABP4, FLT3, PRKCA, PTGES, PTGS2, SRC, TRPV1 |
2.30744 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
BCL2, CDK6, KDR, PIK3CB, PRKCE, SRC |
2.30397 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
HTR2A, HTR2B, HTR2C, KDR, PRKCA, PTPN1, SRC |
2.30141 |
[BP] GO:0050790 |
regulation of catalytic activity
|
AURKB, BCL2, CDC25B, CNR1, CNR2, ESR1, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
2.28229 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B2, HTR2B, HTR2C, IGF1R, KDR, MAOA, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS1, PTGS2, PTPN1, RORC, SRC, TBXAS1, TOP2A, TRPV1, TYR, XDH |
2.28229 |
[BP] GO:0015874 |
None
|
SLC22A1, SLC22A2 |
2.2793 |
[BP] GO:1901374 |
None
|
SLC22A1, SLC22A2 |
2.2793 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.2793 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.2793 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
AKR1B1, HTR2A, MET, PIK3CA, TRPV1 |
2.2793 |
[BP] GO:0043434 |
None
|
APEX1, FABP3, PPARA, PRKCD, PTGS2, SRC, TRPV1 |
2.27343 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
BCL2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB, PRKCB, PRKCE, TRPV1 |
2.27343 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.27343 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM4 |
2.27343 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.27343 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM4 |
2.27343 |
[BP] GO:0007584 |
response to nutrient
|
ALPL, CNR1, CYP1A1, PTGS2, TRPV1, TYR |
2.26008 |
[BP] GO:0040017 |
positive regulation of locomotion
|
BCL2, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
2.26008 |
[BP] GO:0051046 |
None
|
ACHE, CNR1, CYP19A1, HTR2A, HTR2B, HTR2C, MTNR1B, PRKCA, PRKCE, SRC, TRPV1 |
2.2473 |
[BP] GO:0043269 |
regulation of ion transport
|
BCL2, CA2, CA7, CHRM1, CNR1, HTR2A, MMP9, PRKCD, PRKCE, PTGS2 |
2.24554 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B2 |
2.2263 |
[BP] GO:0032098 |
None
|
HTR2C, PPARA, SLC22A3 |
2.2263 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.2263 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, CNR2, HTR2A, PTGS2 |
2.22164 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
HTR2A, HTR2B, HTR2C, KDR, PRKCA, SRC |
2.22164 |
[BP] GO:0050727 |
regulation of inflammatory response
|
CNR1, CNR2, CYP19A1, ESR1, FABP4, PPARA, PRKCD, PTGS2 |
2.20098 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
BCL2, CDK6, CNR1, CNR2, CYP19A1, ESR1, IGF1R, MET, MMP9, PPARA, PRKCB, PRKCD, PTGS2, PTPN1, SRC, XDH |
2.17438 |
[BP] GO:0009987 |
cellular process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B2, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MAOA, MET, MMP1, MMP2, MMP9, MTNR1A, MTNR1B, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS1, PTGS2, PTPN1, RORC, SLC22A1, SLC22A2, SRC, TBXAS1, TOP2A, TRPV1, TYR, XDH |
2.16678 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, IGF1R, MMP2, PRKCD, PTGS2, SRC, TRPV1 |
2.15156 |
[BP] GO:1900076 |
regulation of cellular response to insulin stimulus
|
PRKCB, PRKCD, PTPN1, SRC |
2.15156 |
[BP] GO:0006693 |
None
|
PTGES, PTGS1, PTGS2 |
2.1317 |
[BP] GO:0006692 |
None
|
PTGES, PTGS1, PTGS2 |
2.1317 |
[BP] GO:0045913 |
None
|
HTR2A, PPARA, PRKCE, SRC |
2.12997 |
[BP] GO:0050878 |
regulation of body fluid levels
|
AKR1B1, CHRM1, MET, PRKCA, PRKCD, PRKCE, SLC22A2, XDH |
2.12037 |
[BP] GO:0038096 |
Fc-gamma receptor signaling pathway involved in phagocytosis
|
PIK3CA, PIK3CB, PRKCD, PRKCE, SRC |
2.11546 |
[BP] GO:0002433 |
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis
|
PIK3CA, PIK3CB, PRKCD, PRKCE, SRC |
2.11546 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
CDC25B, FLT3, HTR2A, HTR2B, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC |
2.11546 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1 |
2.11218 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
AURKB, BCL2, CDC25B, ESR1, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TOP2A, XDH |
2.11181 |
[BP] GO:0071502 |
None
|
HTR2B, TRPV1 |
2.09959 |
[BP] GO:0046618 |
None
|
SLC47A1, SLC47A2 |
2.09959 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM4 |
2.0945 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CNR1, CYP1A1, PTGS2, SRC, TRPV1, TYR |
2.0945 |
[BP] GO:0002431 |
Fc receptor mediated stimulatory signaling pathway
|
PIK3CA, PIK3CB, PRKCD, PRKCE, SRC |
2.0945 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, AURKB, AXL, BCL2, CYP1B1, ESR1, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
2.09433 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, MET, PIK3CA, PIK3CB, SRC, XDH |
2.0862 |
[BP] GO:0031330 |
negative regulation of cellular catabolic process
|
BCL2, CNR1, HTR2B, MET, PIK3CA, PRKCG |
2.07631 |
[BP] GO:0010507 |
negative regulation of autophagy
|
BCL2, HTR2B, MET, PIK3CA |
2.07631 |
[BP] GO:0038094 |
Fc-gamma receptor signaling pathway
|
PIK3CA, PIK3CB, PRKCD, PRKCE, SRC |
2.06946 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA |
2.05857 |
[BP] GO:0051223 |
None
|
ACHE, CHRM1, CNR1, HTR2B, MTNR1B, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC |
2.04566 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP19A1, CYP1A1, CYP1B1, MAOA, TYR |
2.04275 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
PTGES, PTGS1, PTGS2 |
2.01887 |
[BP] GO:0033280 |
response to vitamin D
|
ALPL, PTGS2, TYR |
2.01887 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
CDC25B, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC |
2.01748 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
AXL, CNR2, CYP1B1, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PTGS2, SRC |
2.01592 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, FLT3, PTGS2, SRC |
2.01482 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, ESR1, FLT3, GLO1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MMP2, MTNR1A, MTNR1B, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SRC, TRPV1 |
6.79038 |
[CC] GO:0016020 |
membrane
|
ACHE, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FLT3, FUT7, GLO1, HSD17B2, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MAOA, MET, MMP2, MTNR1A, MTNR1B, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS1, PTGS2, PTPN1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SRC, TBXAS1, TRPV1, TYR |
6.5884 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
AXL, CA4, CHRM1, CHRM2, CHRM4, CNR1, CNR2, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MTNR1A, MTNR1B, SLC22A1, SLC22A2, SLC22A3, TRPV1 |
4.79817 |
[CC] GO:0044425 |
membrane part
|
ACHE, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FLT3, FUT7, HSD17B2, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MAOA, MET, MTNR1A, MTNR1B, PIK3CA, PIK3CB, PRKCG, PTGES, PTGS1, PTGS2, PTPN1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SRC, TBXAS1, TRPV1, TYR |
4.74492 |
[CC] GO:0005887 |
integral component of plasma membrane
|
AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MTNR1A, MTNR1B, SLC22A1, SLC22A2, SLC22A3, TRPV1 |
4.49225 |
[CC] GO:0044459 |
plasma membrane part
|
AXL, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MTNR1A, MTNR1B, PRKCG, PTGS2, SLC22A1, SLC22A2, SLC22A3, SRC, TRPV1 |
3.50935 |
[CC] GO:0098590 |
plasma membrane region
|
CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, HTR2A, MET, PRKCG, PTGS2, SLC22A1, SRC, TRPV1 |
2.87333 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, APEX1, CA4, PRKCA, PRKCD, PRKCE, PRKCG, PTGES, SRC, TYR |
2.63667 |
[CC] GO:0031224 |
None
|
ACHE, ALPL, AXL, CA12, CA14, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, ESR1, FLT3, FUT7, HSD17B2, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MAOA, MET, MTNR1A, MTNR1B, PTGES, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, TBXAS1, TRPV1, TYR |
2.05856 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GLO1, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PRKCA, PRKCB, PRKCG, PTPN1, RORC, TBXAS1, TYR, XDH |
11.1969 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CHRM1, CHRM2, CNR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
10.0759 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.7955 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FLT3, GLO1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS1, PTGS2, PTPN1, RORC, SRC, TBXAS1, TOP2A, TRPV1, TYR, XDH |
8.45177 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CHRM1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, FUT7, GLO1, HSD17B2, IGF1R, KDR, MAOA, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS1, PTGS2, PTPN1, SRC, TBXAS1, TOP2A, TYR, XDH |
7.85004 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM4, HTR2A, HTR2B, HTR2C, HTR6 |
6.94308 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GLO1, HTR2A, HTR2B, HTR2C, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, TBXAS1, TOP2A, TRPV1, TYR, XDH |
6.76771 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.56562 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, GLO1, MMP1, MMP2, MMP9, NQO2, PPARA, PRKCA, PRKCB, PRKCG, PTPN1, RORC |
6.28273 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.12689 |
[MF] GO:0008227 |
None
|
CHRM1, CHRM2, CHRM4, HTR2A, HTR2B, HTR2C, HTR6 |
6.0348 |
[MF] GO:0004697 |
None
|
PRKCA, PRKCB, PRKCD, PRKCE, PRKCG |
5.89949 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B2, MAOA, NQO2, PTGS1, PTGS2, TBXAS1, TYR, XDH |
5.45213 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, FLT3, IGF1R, KDR, MET, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
5.2597 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, SRC, TBXAS1 |
5.09659 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GLO1, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, TBXAS1, TOP2A, TRPV1, TYR, XDH |
5.08961 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
5.08961 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
5.08078 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, SRC, TBXAS1 |
4.88972 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB, PRKCD |
4.82323 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.64728 |
[MF] GO:0038023 |
signaling receptor activity
|
AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, ESR1, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MTNR1A, MTNR1B, PPARA, RORC, TRPV1 |
4.61 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, TBXAS1, TYR |
4.58301 |
[MF] GO:0030594 |
None
|
CHRM1, CHRM2, CHRM4, HTR2A, HTR2B, HTR2C, HTR6 |
4.46012 |
[MF] GO:0004698 |
None
|
PRKCA, PRKCB, PRKCG |
4.42612 |
[MF] GO:0060089 |
molecular transducer activity
|
AXL, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, ESR1, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MTNR1A, MTNR1B, PPARA, RORC, TRPV1 |
4.29657 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM4 |
4.08372 |
[MF] GO:0004872 |
receptor activity
|
AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, ESR1, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MTNR1A, MTNR1B, PPARA, RORC, TRPV1 |
3.91932 |
[MF] GO:0004871 |
signal transducer activity
|
AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, ESR1, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MTNR1A, MTNR1B, PPARA, PRKCE, RORC, TRPV1 |
3.88325 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
3.85531 |
[MF] GO:0005329 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
3.82059 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.65792 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, TYR |
3.65792 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, NQO2, PTGES, PTGS1, PTGS2, SRC, TBXAS1, XDH |
3.60715 |
[MF] GO:0004993 |
None
|
HTR2A, HTR2B, HTR2C, HTR6 |
3.60715 |
[MF] GO:0099589 |
None
|
HTR2A, HTR2B, HTR2C, HTR6 |
3.60715 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, XDH |
3.50935 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.4818 |
[MF] GO:0099600 |
transmembrane receptor activity
|
AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MTNR1A, MTNR1B, TRPV1 |
3.40378 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, MET, MTNR1A, MTNR1B, TRPV1 |
3.40378 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.36205 |
[MF] GO:0008504 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
3.3141 |
[MF] GO:0015651 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
3.3141 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
3.22117 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CDK6, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
3.14254 |
[MF] GO:0043176 |
None
|
HTR2A, HTR2B, HTR2C |
3.07423 |
[MF] GO:0051378 |
None
|
HTR2A, HTR2B, HTR2C |
3.07423 |
[MF] GO:0009931 |
None
|
PRKCA, PRKCB, PRKCG |
3.07423 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CDK6, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
3.03046 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CDK6, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
2.99697 |
[MF] GO:0010857 |
None
|
PRKCA, PRKCB, PRKCG |
2.97396 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.94429 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.90059 |
[MF] GO:0035403 |
None
|
PRKCA, PRKCB |
2.90059 |
[MF] GO:0071886 |
None
|
HTR2A, HTR2C |
2.90059 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.69603 |
[MF] GO:0015238 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2 |
2.6519 |
[MF] GO:0035173 |
histone kinase activity
|
AURKB, PRKCA, PRKCB |
2.58516 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM4 |
2.5256 |
[MF] GO:0008502 |
None
|
MTNR1A, MTNR1B |
2.5256 |
[MF] GO:0015307 |
None
|
SLC47A1, SLC47A2 |
2.5256 |
[MF] GO:1901375 |
None
|
SLC22A1, SLC22A2 |
2.5256 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.5256 |
[MF] GO:0005333 |
None
|
SLC22A1, SLC22A2 |
2.5256 |
[MF] GO:0005277 |
None
|
SLC22A1, SLC22A2 |
2.5256 |
[MF] GO:0008513 |
None
|
SLC22A1, SLC22A2 |
2.5256 |
[MF] GO:0004699 |
None
|
PRKCD, PRKCE |
2.5256 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR2A, HTR2B, HTR2C |
2.51114 |
[MF] GO:0004674 |
protein serine/threonine kinase activity
|
AURKB, CDK6, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG |
2.46028 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.42757 |
[MF] GO:0036094 |
small molecule binding
|
AURKB, AXL, CDK6, FABP3, FABP4, FLT3, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1, XDH |
2.3946 |
[MF] GO:0000166 |
nucleotide binding
|
AURKB, AXL, CDK6, FLT3, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1, XDH |
2.33509 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AURKB, AXL, CDK6, FLT3, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1, XDH |
2.33347 |
[MF] GO:0015101 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.2263 |
[MF] GO:0035639 |
purine ribonucleoside triphosphate binding
|
AURKB, AXL, CDK6, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
2.20098 |
[MF] GO:0043168 |
anion binding
|
AURKB, AXL, CDK6, FABP3, FABP4, FLT3, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, SRC, TOP2A, TRPV1, XDH |
2.1276 |
[MF] GO:0032555 |
purine ribonucleotide binding
|
AURKB, AXL, CDK6, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
2.0945 |
[MF] GO:0017076 |
purine nucleotide binding
|
AURKB, AXL, CDK6, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
2.0662 |
[MF] GO:0032553 |
ribonucleotide binding
|
AURKB, AXL, CDK6, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
2.05857 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, HTR2A, HTR2B, HTR2C |
2.03828 |